RA Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

RA Capital Management’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,163,271	Closed	-$109M	–	90
2020 Q3	$109M	Buy	2,163,271 +600	+0%	+$27K	2%	14
2020 Q2	$103M	Hold	2,162,671	–	–	2.01%	18
2020 Q1	$106M	Hold	2,162,671	–	–	3.35%	7
2019 Q4	$124M	Hold	2,162,671	–	–	3.76%	7
2019 Q3	$77.8M	Hold	2,162,671	–	–	4.63%	6
2019 Q2	$113M	Hold	2,162,671	–	–	6.05%	6
2019 Q1	$91.1M	Hold	2,162,671	–	–	3.93%	8
2018 Q4	$59.2M	Hold	2,162,671	–	–	3.45%	10
2018 Q3	$21.6M	Hold	2,162,671	–	–	1.15%	19
2018 Q2	$44M	Buy	+2,162,671	New	+$45.3M	2.86%	14

Other funds holding EIDX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return